NCT06523751

Brief Summary

The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 26, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

April 3, 2025

Status Verified

April 1, 2025

Enrollment Period

2.6 years

First QC Date

July 16, 2024

Last Update Submit

April 2, 2025

Conditions

Keywords

Ab Interno TrabeculectomyTrabeculopunctureOpen Angle Glaucoma

Outcome Measures

Primary Outcomes (3)

  • IOP

    Intraocular pressure measured by Goldmann applanation tonometry

    before and two hours after trabeculopuncture, one and four weeks postoperatively (after ab interno trabeculectomy), and three months postoperatively

  • Outflow facility

    Outflow facility is measured by the use of a pneumatonometer

    before and two hours after trabeculopuncture, one and four weeks postoperatively (after ab interno trabeculectomy), and three months postoperatively

  • Surgical success

    surgical success at month three is defined as 20% IOP reduction without increasing the number of glaucoma drops

    at month three

Study Arms (1)

Trabeculopuncture

EXPERIMENTAL

Individuals undergo neodymium-doped yttrium aluminum garnet (Nd:YAG) trabeculopuncture prior to ab interno trabeculectomy.

Diagnostic Test: Trabeculopuncture

Interventions

TrabeculopunctureDIAGNOSTIC_TEST

Trabeculopuncture is performed with a Nd:YAG laser on the trabecular meshwork. Four punctures are created along the 180° nasal trabecular meshwork.

Trabeculopuncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals ≥ 18 years of age
  • clinical diagnosis of: primary open angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma
  • uncontrolled intraocular pressure (IOP) with maximally tolerated medical therapy
  • progressive thinning of retinal nerve fiber layer assessed by Spectral domain optical coherence tomography (p \< 0.05)
  • progression of visual field defects
  • visually significant cataract and indication to reduce IOP or glaucoma medication burden

You may not qualify if:

  • clinical diagnosis of neovascular glaucoma, angle-closure glaucoma, uveitic glaucoma, neovascular glaucoma
  • prior glaucoma surgery
  • preexisting conditions affecting the episcleral venous pressure including Grave's ophthalmopathy, Sturge-Weber syndrome, Arteriovenous fistulas (carotid-cavernous fistula)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uniklinikum Würzburg

Würzburg, Bavaria, 97080, Germany

RECRUITING

Related Publications (4)

  • Verma-Fuehring R, Dakroub M, Han H, Hillenkamp J, Loewen NA. Trabeculopuncture as a predictive test of distal outflow resistance in canal-based surgery. Sci Rep. 2022 Jun 22;12(1):10584. doi: 10.1038/s41598-022-13990-9.

    PMID: 35732782BACKGROUND
  • Epstein DL, Melamed S, Puliafto CA, Steinert RF. Neodymium: YAG laser trabeculopuncture in open-angle glaucoma. Ophthalmology. 1985 Jul;92(7):931-7. doi: 10.1016/s0161-6420(85)33932-5.

    PMID: 4022580BACKGROUND
  • Melamed S, Pei J, Puliafito CA, Epstein DL. Q-switched neodymium-YAG laser trabeculopuncture in monkeys. Arch Ophthalmol. 1985 Jan;103(1):129-33. doi: 10.1001/archopht.1985.01050010135037.

    PMID: 3977666BACKGROUND
  • Del Priore LV, Robin AL, Pollack IP. Long-term follow-up of neodymium: YAG laser angle surgery for open-angle glaucoma. Ophthalmology. 1988 Feb;95(2):277-81. doi: 10.1016/s0161-6420(88)33195-7.

    PMID: 3173993BACKGROUND

MeSH Terms

Conditions

Glaucoma, Open-AngleExfoliation Syndrome

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye DiseasesIris DiseasesUveal Diseases

Study Officials

  • Daniel Kampik, MD, PhD

    Department of Ophthalmology University Hospital Würzburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Raoul Verma-Fuehring, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Determining Distal Outflow Tract Function in Open Angle Glaucoma as a Predictive Test for the Success of Ab Interno Trabeculectomy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

July 26, 2024

Study Start

June 13, 2023

Primary Completion

December 31, 2025

Study Completion

January 31, 2026

Last Updated

April 3, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations